Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative anemia and extensive transfusion during stay-in-hospital are critical for patient`s mortality: A retrospective multicenter cohort study of oncological patients undergoing radical cystectomy.
Ceanga AI, Ceanga M, Eveslage M, Herrmann E, Fischer D, Haferkamp A, Wittmann M, Müller S, Van Aken H, Steinbicker AU. Ceanga AI, et al. Among authors: muller s. Transfus Apher Sci. 2018 Dec;57(6):739-745. doi: 10.1016/j.transci.2018.08.003. Epub 2018 Sep 5. Transfus Apher Sci. 2018. PMID: 30301602
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ. May M, et al. Among authors: muller sc. Ann Surg Oncol. 2011 Jul;18(7):2018-25. doi: 10.1245/s10434-010-1538-6. Epub 2011 Jan 19. Ann Surg Oncol. 2011. PMID: 21246405
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Fritsche HM. May M, et al. BJU Int. 2011 Oct;108(8 Pt 2):E278-83. doi: 10.1111/j.1464-410X.2011.10189.x. Epub 2011 Jun 23. BJU Int. 2011. PMID: 21699644
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ. Nuhn P, et al. Among authors: muller sc. Eur Urol. 2012 Jan;61(1):58-64. doi: 10.1016/j.eururo.2011.07.066. Epub 2011 Aug 9. Eur Urol. 2012. PMID: 21840642
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. May M, et al. Among authors: muller sc. Urol Oncol. 2013 Oct;31(7):1141-7. doi: 10.1016/j.urolonc.2011.09.011. Epub 2011 Nov 6. Urol Oncol. 2013. PMID: 22056404
External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.
May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. May M, et al. Among authors: muller sc. J Urol. 2012 Apr;187(4):1210-4. doi: 10.1016/j.juro.2011.11.104. Epub 2012 Feb 14. J Urol. 2012. PMID: 22335861
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M. Otto W, et al. Among authors: muller sc. Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001. Gend Med. 2012. PMID: 23217567
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L. Bolenz C, et al. Among authors: muller sc. BJU Int. 2010 Aug;106(4):493-9. doi: 10.1111/j.1464-410X.2009.09166.x. Epub 2010 Jan 8. BJU Int. 2010. PMID: 20067452 Clinical Trial.
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ. May M, et al. Among authors: muller sc. Eur Urol. 2011 May;59(5):712-8. doi: 10.1016/j.eururo.2011.01.030. Epub 2011 Jan 28. Eur Urol. 2011. PMID: 21296488
Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM. May M, et al. Among authors: muller sc. Scand J Urol Nephrol. 2011 Sep;45(4):251-7. doi: 10.3109/00365599.2011.562235. Epub 2011 Mar 10. Scand J Urol Nephrol. 2011. PMID: 21388337
5,544 results